Copyright Reports & Markets. All rights reserved.

Global Minimally Invasive Female Urinary Incontinence Devices Market Research Report 2021

Request for Sample of this report
Buy now

1 Minimally Invasive Female Urinary Incontinence Devices Market Overview

  • 1.1 Product Overview and Scope of Minimally Invasive Female Urinary Incontinence Devices
  • 1.2 Minimally Invasive Female Urinary Incontinence Devices Segment by Type
    • 1.2.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 External Urinary Incontinence Devices
    • 1.2.3 Internal Urinary Incontinence Devices
  • 1.3 Minimally Invasive Female Urinary Incontinence Devices Segment by Application
    • 1.3.1 Minimally Invasive Female Urinary Incontinence Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Ambulatory Surgical Centers
    • 1.3.3 Gynecology Clinics
    • 1.3.4 Hospitals
  • 1.4 Global Minimally Invasive Female Urinary Incontinence Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Minimally Invasive Female Urinary Incontinence Devices Revenue 2016-2027
    • 1.4.2 Global Minimally Invasive Female Urinary Incontinence Devices Sales 2016-2027
    • 1.4.3 Minimally Invasive Female Urinary Incontinence Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Minimally Invasive Female Urinary Incontinence Devices Market Competition by Manufacturers

  • 2.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Minimally Invasive Female Urinary Incontinence Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Minimally Invasive Female Urinary Incontinence Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Minimally Invasive Female Urinary Incontinence Devices Market Competitive Situation and Trends
    • 2.5.1 Minimally Invasive Female Urinary Incontinence Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Minimally Invasive Female Urinary Incontinence Devices Players Market Share by Revenue
    • 2.5.3 Global Minimally Invasive Female Urinary Incontinence Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Minimally Invasive Female Urinary Incontinence Devices Retrospective Market Scenario by Region

  • 3.1 Global Minimally Invasive Female Urinary Incontinence Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Minimally Invasive Female Urinary Incontinence Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Minimally Invasive Female Urinary Incontinence Devices Market Facts & Figures by Country
    • 3.3.1 North America Minimally Invasive Female Urinary Incontinence Devices Sales by Country
    • 3.3.2 North America Minimally Invasive Female Urinary Incontinence Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Minimally Invasive Female Urinary Incontinence Devices Market Facts & Figures by Country
    • 3.4.1 Europe Minimally Invasive Female Urinary Incontinence Devices Sales by Country
    • 3.4.2 Europe Minimally Invasive Female Urinary Incontinence Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Minimally Invasive Female Urinary Incontinence Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Minimally Invasive Female Urinary Incontinence Devices Sales by Region
    • 3.5.2 Asia Pacific Minimally Invasive Female Urinary Incontinence Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Minimally Invasive Female Urinary Incontinence Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Minimally Invasive Female Urinary Incontinence Devices Sales by Country
    • 3.6.2 Latin America Minimally Invasive Female Urinary Incontinence Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Minimally Invasive Female Urinary Incontinence Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Minimally Invasive Female Urinary Incontinence Devices Sales by Country
    • 3.7.2 Middle East and Africa Minimally Invasive Female Urinary Incontinence Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Minimally Invasive Female Urinary Incontinence Devices Historic Market Analysis by Type

  • 4.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Minimally Invasive Female Urinary Incontinence Devices Price by Type (2016-2021)

5 Global Minimally Invasive Female Urinary Incontinence Devices Historic Market Analysis by Application

  • 5.1 Global Minimally Invasive Female Urinary Incontinence Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Minimally Invasive Female Urinary Incontinence Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Minimally Invasive Female Urinary Incontinence Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Axonics Modulation Technologies, Inc
    • 6.1.1 Axonics Modulation Technologies, Inc Corporation Information
    • 6.1.2 Axonics Modulation Technologies, Inc Description and Business Overview
    • 6.1.3 Axonics Modulation Technologies, Inc Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Axonics Modulation Technologies, Inc Product Portfolio
    • 6.1.5 Axonics Modulation Technologies, Inc Recent Developments/Updates
  • 6.2 Bioness, Inc.
    • 6.2.1 Bioness, Inc. Corporation Information
    • 6.2.2 Bioness, Inc. Description and Business Overview
    • 6.2.3 Bioness, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Bioness, Inc. Product Portfolio
    • 6.2.5 Bioness, Inc. Recent Developments/Updates
  • 6.3 BlueWind Medical Ltd.
    • 6.3.1 BlueWind Medical Ltd. Corporation Information
    • 6.3.2 BlueWind Medical Ltd. Description and Business Overview
    • 6.3.3 BlueWind Medical Ltd. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 BlueWind Medical Ltd. Product Portfolio
    • 6.3.5 BlueWind Medical Ltd. Recent Developments/Updates
  • 6.4 Boston Scientific Corporation
    • 6.4.1 Boston Scientific Corporation Corporation Information
    • 6.4.2 Boston Scientific Corporation Description and Business Overview
    • 6.4.3 Boston Scientific Corporation Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Boston Scientific Corporation Product Portfolio
    • 6.4.5 Boston Scientific Corporation Recent Developments/Updates
  • 6.5 Caldera Medical, Inc.
    • 6.5.1 Caldera Medical, Inc. Corporation Information
    • 6.5.2 Caldera Medical, Inc. Description and Business Overview
    • 6.5.3 Caldera Medical, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Caldera Medical, Inc. Product Portfolio
    • 6.5.5 Caldera Medical, Inc. Recent Developments/Updates
  • 6.6 Carbon Medical Technologies, Inc.
    • 6.6.1 Carbon Medical Technologies, Inc. Corporation Information
    • 6.6.2 Carbon Medical Technologies, Inc. Description and Business Overview
    • 6.6.3 Carbon Medical Technologies, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Carbon Medical Technologies, Inc. Product Portfolio
    • 6.6.5 Carbon Medical Technologies, Inc. Recent Developments/Updates
  • 6.7 CL Medical
    • 6.6.1 CL Medical Corporation Information
    • 6.6.2 CL Medical Description and Business Overview
    • 6.6.3 CL Medical Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 CL Medical Product Portfolio
    • 6.7.5 CL Medical Recent Developments/Updates
  • 6.8 Cogentix Medical, Coloplast Corporation, Cousin Biotech
    • 6.8.1 Cogentix Medical, Coloplast Corporation, Cousin Biotech Corporation Information
    • 6.8.2 Cogentix Medical, Coloplast Corporation, Cousin Biotech Description and Business Overview
    • 6.8.3 Cogentix Medical, Coloplast Corporation, Cousin Biotech Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Cogentix Medical, Coloplast Corporation, Cousin Biotech Product Portfolio
    • 6.8.5 Cogentix Medical, Coloplast Corporation, Cousin Biotech Recent Developments/Updates
  • 6.9 C. R. Bard, Inc. (Becton, Dickinson and Company)
    • 6.9.1 C. R. Bard, Inc. (Becton, Dickinson and Company) Corporation Information
    • 6.9.2 C. R. Bard, Inc. (Becton, Dickinson and Company) Description and Business Overview
    • 6.9.3 C. R. Bard, Inc. (Becton, Dickinson and Company) Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 C. R. Bard, Inc. (Becton, Dickinson and Company) Product Portfolio
    • 6.9.5 C. R. Bard, Inc. (Becton, Dickinson and Company) Recent Developments/Updates
  • 6.10 Ethicon, Inc./Johnson & Johnson
    • 6.10.1 Ethicon, Inc./Johnson & Johnson Corporation Information
    • 6.10.2 Ethicon, Inc./Johnson & Johnson Description and Business Overview
    • 6.10.3 Ethicon, Inc./Johnson & Johnson Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Ethicon, Inc./Johnson & Johnson Product Portfolio
    • 6.10.5 Ethicon, Inc./Johnson & Johnson Recent Developments/Updates
  • 6.11 FemPulse, LLC
    • 6.11.1 FemPulse, LLC Corporation Information
    • 6.11.2 FemPulse, LLC Minimally Invasive Female Urinary Incontinence Devices Description and Business Overview
    • 6.11.3 FemPulse, LLC Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 FemPulse, LLC Product Portfolio
    • 6.11.5 FemPulse, LLC Recent Developments/Updates
  • 6.12 InterStim, Medtronic, Inc.
    • 6.12.1 InterStim, Medtronic, Inc. Corporation Information
    • 6.12.2 InterStim, Medtronic, Inc. Minimally Invasive Female Urinary Incontinence Devices Description and Business Overview
    • 6.12.3 InterStim, Medtronic, Inc. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 InterStim, Medtronic, Inc. Product Portfolio
    • 6.12.5 InterStim, Medtronic, Inc. Recent Developments/Updates
  • 6.13 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA
    • 6.13.1 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Corporation Information
    • 6.13.2 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Minimally Invasive Female Urinary Incontinence Devices Description and Business Overview
    • 6.13.3 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Product Portfolio
    • 6.13.5 Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA Recent Developments/Updates
  • 6.14 NURO Sys
    • 6.14.1 NURO Sys Corporation Information
    • 6.14.2 NURO Sys Minimally Invasive Female Urinary Incontinence Devices Description and Business Overview
    • 6.14.3 NURO Sys Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 NURO Sys Product Portfolio
    • 6.14.5 NURO Sys Recent Developments/Updates
  • 6.15 Nuvectra Corporation
    • 6.15.1 Nuvectra Corporation Corporation Information
    • 6.15.2 Nuvectra Corporation Minimally Invasive Female Urinary Incontinence Devices Description and Business Overview
    • 6.15.3 Nuvectra Corporation Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Nuvectra Corporation Product Portfolio
    • 6.15.5 Nuvectra Corporation Recent Developments/Updates
  • 6.16 StimGuard LLC.
    • 6.16.1 StimGuard LLC. Corporation Information
    • 6.16.2 StimGuard LLC. Minimally Invasive Female Urinary Incontinence Devices Description and Business Overview
    • 6.16.3 StimGuard LLC. Minimally Invasive Female Urinary Incontinence Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 StimGuard LLC. Product Portfolio
    • 6.16.5 StimGuard LLC. Recent Developments/Updates

7 Minimally Invasive Female Urinary Incontinence Devices Manufacturing Cost Analysis

  • 7.1 Minimally Invasive Female Urinary Incontinence Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Minimally Invasive Female Urinary Incontinence Devices
  • 7.4 Minimally Invasive Female Urinary Incontinence Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Minimally Invasive Female Urinary Incontinence Devices Distributors List
  • 8.3 Minimally Invasive Female Urinary Incontinence Devices Customers

9 Minimally Invasive Female Urinary Incontinence Devices Market Dynamics

  • 9.1 Minimally Invasive Female Urinary Incontinence Devices Industry Trends
  • 9.2 Minimally Invasive Female Urinary Incontinence Devices Growth Drivers
  • 9.3 Minimally Invasive Female Urinary Incontinence Devices Market Challenges
  • 9.4 Minimally Invasive Female Urinary Incontinence Devices Market Restraints

10 Global Market Forecast

  • 10.1 Minimally Invasive Female Urinary Incontinence Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Minimally Invasive Female Urinary Incontinence Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Minimally Invasive Female Urinary Incontinence Devices by Type (2022-2027)
  • 10.2 Minimally Invasive Female Urinary Incontinence Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Minimally Invasive Female Urinary Incontinence Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Minimally Invasive Female Urinary Incontinence Devices by Application (2022-2027)
  • 10.3 Minimally Invasive Female Urinary Incontinence Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Minimally Invasive Female Urinary Incontinence Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Minimally Invasive Female Urinary Incontinence Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    External Urinary Incontinence Devices
    Internal Urinary Incontinence Devices

    Segment by Application
    Ambulatory Surgical Centers
    Gynecology Clinics
    Hospitals

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Axonics Modulation Technologies, Inc
    Bioness, Inc.
    BlueWind Medical Ltd.
    Boston Scientific Corporation
    Caldera Medical, Inc.
    Carbon Medical Technologies, Inc.
    CL Medical
    Cogentix Medical, Coloplast Corporation, Cousin Biotech
    C. R. Bard, Inc. (Becton, Dickinson and Company)
    Ethicon, Inc./Johnson & Johnson
    FemPulse, LLC
    InterStim, Medtronic, Inc.
    Merz Aesthetics, Inc./Merz Pharma GmbH & Co. KGaA
    NURO Sys
    Nuvectra Corporation
    StimGuard LLC.

    Buy now